Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Added some more $.0009's today let's roll
SSHS looking beautiful here $.007 x $.0072 let's stay above resistance now and let it become support
$30,000 worth just bought at $.0067 on bid...someone is putting their money where their mouth is
I agree. The stock put in a double bottom on the chart at $.0031. From a fundamental standpoint, everything looks clear for lift off here. From a technical standpoint, we need to break and close above $.007 to really signal a chart breakout
HUGE news out...company's gotta be worth a couple cents atleast
Agreed. Today looks like the stock was consolidation after record volume and large run up yesterday...should head north again tomorrow
WTAI record volume yesterday looking like a VKNG in its early stages
lock and load
WTAI record volume yesterday looking like a VKNG in its early stages
WTAI record volume yesterday looking like a VKNG in its early stages
Anyone else see the recent Form 4 insider stock purchase? That could have something to do with yesterdays volume. Perhaps the company has some exciting things going on behind the scenes that they are preparing to announce. These things always leak out so most likely someone knows something and is buying in anticipation of it.
WTAI lets break $.005
WTAI flying $.0045 x $.005 on RECORD volume
WTAI holding for $.01+ tomorrow...hearing $.05 coming
check the filings...there's also a recent Form 4...insider stock purchase
WTAI >>> vroom vroom party about to get started
WTAI $.01+ by tomorrow
WTAI don't miss this one
WTAI don't miss this one
WTAI huge momo starting here...looking for $.01+
holding VGPR for $.10+
VKNG power hour approaching IMO
Bio-Solutions Corp. is Proud to Announce the Negotiation of Supply Agreement With the Government of 3 African Countries for Gree
MONTREAL, CANADA -- (Marketwire) -- 11/10/09 -- Bio-Solutions Corp. (OTCBB: BISU), is proud to announce the negotiation of a supply agreement for its main product GreenEx(TM) with three African Countries. This agreement will include the turn key operation of the spreading of GreenEx(TM) on highly infested sites within these countries.
'During our commercialization efforts of GreenEx(TM), we have realized that our integrated participative approach in highly infested countries gives Bio-Solutions Corp a significant competitive edge.' states Dr Chaumillon.
Management at Bio-Solutions Corp. has begun development activities less than 6 month ago in 3 countries. It allowed the company to validate its approach and to evaluate that it fulfils real needs. In a specific country, GreenEx(TM) has been regulatory approved to be used in a pilot study to demonstrate efficiency in a specific area highly infested and to confirm previous results obtained in different geographic area and different environmental conditions.
'It is important to mention that the environmental conditions and prevalent factors are area specific and require validation of spreading techniques in order to be adequately deployed. In that respect, due to the country specific project sizes, we need to develop partnership with health authority's upper management as well as respective government highest level of decision. Our intention is to develop long term multiple partnership to allow Bio-Solutions Corp. to reach profitability during the first year of operation and thus assure recurrent and significant revenues to the company while helping the fight against Malaria vectors, within these Malaria infested countries' indicated Dr Chaumillon.
For more information on Bio-Solutions Corp. and its products, please visit the company's website at www.bio-solutionscorp.com
Forward-Looking Statements
This press release contains forward-looking statements made pursuant to the safe harbour provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Bio-Solutions' actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of studies, the ability of the Company to take advantage of business opportunities in the biotechnology industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements and disclaims any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments, except if we are requested by a governmental authority or applicable law.
Contacts:
Adrian McKenzie
Investor & Public Relations
Bio-Solutions Corp. is Proud to Announce the Negotiation of Supply Agreement With the Government of 3 African Countries for Gree
MONTREAL, CANADA -- (Marketwire) -- 11/10/09 -- Bio-Solutions Corp. (OTCBB: BISU), is proud to announce the negotiation of a supply agreement for its main product GreenEx(TM) with three African Countries. This agreement will include the turn key operation of the spreading of GreenEx(TM) on highly infested sites within these countries.
'During our commercialization efforts of GreenEx(TM), we have realized that our integrated participative approach in highly infested countries gives Bio-Solutions Corp a significant competitive edge.' states Dr Chaumillon.
Management at Bio-Solutions Corp. has begun development activities less than 6 month ago in 3 countries. It allowed the company to validate its approach and to evaluate that it fulfils real needs. In a specific country, GreenEx(TM) has been regulatory approved to be used in a pilot study to demonstrate efficiency in a specific area highly infested and to confirm previous results obtained in different geographic area and different environmental conditions.
'It is important to mention that the environmental conditions and prevalent factors are area specific and require validation of spreading techniques in order to be adequately deployed. In that respect, due to the country specific project sizes, we need to develop partnership with health authority's upper management as well as respective government highest level of decision. Our intention is to develop long term multiple partnership to allow Bio-Solutions Corp. to reach profitability during the first year of operation and thus assure recurrent and significant revenues to the company while helping the fight against Malaria vectors, within these Malaria infested countries' indicated Dr Chaumillon.
For more information on Bio-Solutions Corp. and its products, please visit the company's website at www.bio-solutionscorp.com
Forward-Looking Statements
This press release contains forward-looking statements made pursuant to the safe harbour provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Bio-Solutions' actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of studies, the ability of the Company to take advantage of business opportunities in the biotechnology industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements and disclaims any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments, except if we are requested by a governmental authority or applicable law.
Contacts:
Adrian McKenzie
Investor & Public Relations
if you drop it down to 003 i'll buy
is that you on the offer of that healthcare company at 0035
wow...unreal. MM's taking us down on low volume
Cali where you been?
o.k. lets shift the tides in the right direction today
BISU...patience sold seperately...lol
BISU classic MM shake on light volume day...
perfect opp for new money to come in here IMO
looks like a light volume pull back...usually a great opportunity to snag up some cheapies on the bid as impatient players look to exit to chase other plays.
when you're the first ones in, ground level sometimes feels lonely
I agree with you. BISU is consolidating at this level.
once the momo gets jumpstarted here we are off to the races.
BISU looking ready to break out from here
L2 looks clear to $.85
Bio-Solutions Corp. Announces its First Distribution Agreement of NutraAnimalTM With Jupiter Agro-Biotech Inc., for the Canadian Market
MONTREAL, CANADA--(Marketwire - Nov. 3, 2009) - Bio-Solutions Corp. (OTCBB:BISU), announces that this first distribution agreement represents a minimum of 350,000$ in revenues for the first year with potential revenues of one million in the next twelve months in the Canadian poultry market. Jupiter Agro-Biotech is a company specialized in feed supplements for livestock and of the distribution of these supplements in Canada. "Jupiter Agro-Biotech Inc. is one of the major Canadian distributors in the field" indicates CEO, Dr. Gilles Chaumillon. The American poultry market in itself represents multi million dollars in revenues for Bio-Solutions Corp, at maturity.
NutraAnimalTM is an active organic dietary supplement which improves the chicken's anti-oxidant defence system and decrease oxidative stress, allowing for more sustainable growth. This product can also be used as supplement for large animal to achieve the same benefits. With present experiments being conducted, Bio-Solutions Corp will be able to evaluate the advantages and the increase in output that the product may possibly offer. Unquestionably, favourable results will offer this product a colossal market opportunity in a large market. "The use of more potent organic molecules or innovative complex than those currently on the market, with a better safety profile have an immense market potential for humans, in the veterinary field, or for animal care as well", added Dr. Gilles Chaumillon, CEO.
Bio-Solutions Corp is a biotechnology company specializing in veterinary care and organic dietary supplement for livestock and domestic animals. Jupiter Agro-biotech, based in Saint-Hyacinthe, Quebec, is one of the major Canadian distributors of food supplements for livestock breeding and domestic pet care products.
For more information on Bio-Solutions Corp. and its products, please visit the company's website at www.bio-solutionscorp.com
Forward-Looking Statements
This press release contains forward-looking statements made pursuant to the safe harbour provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Bio-Solutions' actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R&D projects, the successful and timely completion of studies, the ability of the Company to take advantage of business opportunities in the biotechnology industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements and disclaims any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments, except if we are requested by a governmental authority or applicable law.
For more information, please contact
Investor & Public Relations:
Adrian McKenzie
561-654-5722
pbdcllc@gmail.com
feels like the calm before the storm...looking for $1+ this week